| Similar Articles |
|---|
 |
The Motley Fool
December 13, 2011
Brian Orelli |
Dividend? Buyback? Here's How to Get Both. But will there be enough to replenish the pipeline?   |
The Motley Fool
March 23, 2011
Todd Wenning |
Dividend Report Card: Pfizer Investors considering Pfizer as a dividend play should decide if the combination of 4% current yield and low- to mid-single-digit dividend growth potential is a better deal than other pharmaceutical shares are offering. |
The Motley Fool
August 29, 2008
Brian Orelli |
Can Health-Care Dividends Hold Up? As many health-care companies' share prices drop, their dividend yields have become strikingly attractive. The big question, though, is whether these dividends can hold up. |
The Motley Fool
December 26, 2006
Rick Aristotle Munarriz |
4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. State Street... Pfizer... Eli Lilly... The Andersons... |
The Motley Fool
February 22, 2007
Ryan Fuhrmann |
Dueling Fools: Pfizer Bull The drug giant has ample firepower. The current company valuation largely ignores Pfizer's upside potential past 2008. |
The Motley Fool
December 18, 2008
Brian Orelli |
Best Stock for 2009: Pfizer Pfizer's languishing stock price has made the company so much more attractive; it could see a breakout in 2009. |
The Motley Fool
August 13, 2010
Ilan Moscovitz |
Merck: Dividend Dynamo or Disaster? Just how safe is this dividend? |
The Motley Fool
August 30, 2010
Ilan Moscovitz |
Pfizer: Dividend Dynamo or Disaster? The stability and growth of Pfizer's dividend will depend on its ability to continue to develop and grow its pipeline of drugs and successfully integrate Wyeth. |
The Motley Fool
August 26, 2010
Jordan DiPietro |
Pfizer's Dividends May Not Last Forever Pfizer, which operates in the pharmaceuticals industry, currently pays a dividend of 4.5%. But what's more important than the dividend itself is Pfizer's ability to keep that that cash rolling. |
The Motley Fool
February 8, 2010
Selena Maranjian |
Good News About the Worst Year It's over. Remember, the overall trend of the market is up. When stocks of good, healthy, and growing companies get beaten down, they're likely to regain their footing. |
The Motley Fool
August 23, 2010
Jordan DiPietro |
How Safe Are Eli Lilly's Dividends? Check out how Eli Lilly stacks up |
The Motley Fool
May 3, 2006
Selena Maranjian |
When Dividends Are Dicey A hefty dividend yield isn't always something investors can count on. |
The Motley Fool
December 24, 2007
Rick Aristotle Munarriz |
4 Stocks That Took a Hike These stocks recently raised their dividends: Pfizer... Eli Lilly... Moody's... Waste Management... |
The Motley Fool
January 23, 2007
Ryan Fuhrmann |
Pfizer Pfizzles Through 2006 The company is in a top-line pickle, but it expects things to get better. Current investors are now left standing until a rebound in growth, now targeted for 2009. |
The Motley Fool
December 19, 2005
Rick Aristotle Munarriz |
4 Companies That Took a Hike Companies with growing yields can make you rich in more ways than the obvious: General Mills... Microsoft... Pfizer... T. Rowe Price... |
The Motley Fool
June 8, 2011
Eben Esterhuizen |
Profit Payouts: Companies Offering Sustainable Growth While Boosting Dividends These companies are firing on all cylinders: Republic Bancorp... First Commonwealth Financial... Commerce Bancshares... Hormel Foods... |
The Motley Fool
September 30, 2010
Brian Orelli |
Chief Justice Roberts Sold Pfizer. Should You? Maybe, but not for the same reason. |
The Motley Fool
June 15, 2006
Selena Maranjian |
My Dividends Are Bigger Than Yours Your yield may be 2% when mine is a whopping 13%. Here's the secret. |
The Motley Fool
January 5, 2008
Adam J. Wiederman |
Bear Market Buys How to find the best investments when the market is tough. |
The Motley Fool
July 22, 2009
Selena Maranjian |
These Dividend Stocks Have It All You don't have to choose between high yields and dividend growth as companies like BP, CNOOC, Chevron, Waste Management, Home Depot, Kraft, and Caterpillar will demonstrate. |
The Motley Fool
January 5, 2012
Dan Caplinger |
Expect These Aristocrats to Pay You More Soon If you want higher dividends, these Aristocrats are worth keeping an eye on. |
The Motley Fool
January 26, 2009
Brian Orelli |
Deja Vu All Over Again There's hardly anything to like about Pfizer's deal to buy Wyeth. This is what got Pfizer into its problem in the first place. |
The Motley Fool
January 28, 2009
Brian Orelli |
A Mini-Pfizer in the Making Bristol-Myers Squibb looks like its setting itself up to be the next Pfizer. |
The Motley Fool
May 19, 2009
Selena Maranjian |
Frightening News About Dividend Stocks For dividend lovers, the past year has been brutal. Dividend cuts have come at the fastest pace in 50 or more years. Check out some of these not-so-obscure companies that have cut their dividend in the past 12 months. |
The Motley Fool
April 25, 2011
Brian Orelli |
Dividend Investors Rejoice! Or Not. Amgen establishes a dividend, investors yawn. |
The Motley Fool
June 11, 2010
Morgan Housel |
5 Dividend Monsters to Buy After the Crash The good news is that the recent crash has turned some traditional dividend stocks into veritable cash cows. Here are five: AT&T... Verizon... Altria... Southern Company... Eli Lilly... |
The Motley Fool
February 25, 2011
Todd Wenning |
Dividend Report Card: Bristol-Myers Squibb How does the pharma giant's dividend stack up? |
The Motley Fool
November 23, 2009
Dan Caplinger |
Are These Dividends Too Good to Be True? Lots of high-yielding stocks won't last. Look for history and earnings. |
The Motley Fool
May 12, 2010
Selena Maranjian |
3 Signs of a Strong Dividend Not all dividends are created equal. Here's how to find the best candidates for your portfolio. |
The Motley Fool
June 11, 2008
Brian Lawler |
Dueling Fools: Pfizer Bear Is Pfizer ready for a comeback? The bearish opinion is that shares may be down, but the bleeding still isn't over. |
The Motley Fool
November 25, 2009
Jennifer Schonberger |
7 Dividend Divas Check out these income stocks for steady dividend returns: Alliance Resource Partners... Altria Group... AT&T... Bristol-Myers Squibb... Southern Company... Eli Lilly... Verizon... |
The Motley Fool
October 30, 2009
Brian Orelli |
World's Scariest Stocks: Pfizer For Pfizer, the big, scary unknown comes from whether it can integrate its recent acquisition of Wyeth. |
The Motley Fool
October 24, 2007
Selena Maranjian |
Meet the Dividend Achievers If you're looking for dividend-paying stocks, you need to know the Mergent Dividend Achievers. |
The Motley Fool
January 24, 2008
Selena Maranjian |
Which Dividends Can You Count On? Some dividends are safe; while others are at risk. |
The Motley Fool
April 17, 2007
Ryan Fuhrmann |
Clean Bill of Health at Eli Lilly Lilly recorded another solid quarter, but its valuation is a little rich. |
The Motley Fool
June 8, 2011
Eben Esterhuizen |
High Yield: Highly Profitable Companies With Rising Dividends Will these companies help you you minimize the risk of investing in a dividend stock that's about to end its winning streak? |
The Motley Fool
April 6, 2009
Selena Maranjian |
How You Can Enjoy a 25% Dividend Yield Pay attention to the dividend growth rates of your investments, because a rapidly growing dividend can give you a steep yield on cost in a number of years. |
The Motley Fool
January 12, 2012
Brian Orelli |
What to Look For From Pfizer in 2012 Leaner? Yes. Meaner? We'll see. |
The Motley Fool
June 30, 2011
Brian Orelli |
Biotech Winners of a Repatriation Holiday Biotechs and dividend players will come out ahead. |
The Motley Fool
August 18, 2010
Jordan DiPietro |
How Long Will Merck's Dividend Last? Check out how Merck stacks up in this article. |
The Motley Fool
March 31, 2011
Todd Wenning |
Dividend Sector Review: Pharmaceuticals These pharmaceutical stocks generate an adequate amount of free cash flow to fund their well above-average dividend yields. |
The Motley Fool
December 23, 2009
Brian Orelli |
2009 Cheers and Jeers for Pharma Unfortunately, it was more of the latter. |
The Motley Fool
November 30, 2011
Brian Orelli |
3 Things More Important to Pfizer Than Losing Lipitor It's not like we didn't see it coming. |
The Motley Fool
June 11, 2008
Brian Orelli |
Dueling Fools: Pfizer Bull The bullish opinion on Pfizer is that this may be the best time to buy this stock. |
The Motley Fool
August 12, 2010
Morgan Housel |
Is Paychex's Dividend in Jeopardy? Looking at the cash flow statement, it doesn't appear so. |
The Motley Fool
July 22, 2008
Adam J. Wiederman |
Stocks to Get You Through the Bear Market You do want to survive, right? |
The Motley Fool
September 15, 2010
Jim Royal |
Secure Your Future With These Stocks Dividend payers can give your portfolio an extra line of defense. |
The Motley Fool
December 20, 2006
Selena Maranjian |
Buy Tomorrow's Big Yields Today Before it's too late, snap up a future 20% yield. The key is finding companies that have the fiscal strength to raise their dividend year after year. And they're out there. |
The Motley Fool
December 15, 2010
Esterhuizen & Sellitti |
Dividend Ideas: 2011 Dogs of the Dow Sticking to this investing approach has yielded impressive gains for its proponents. |
The Motley Fool
November 7, 2011
Tamara Rutter |
It Pays to Invest Like a Dog Find out how the Dow's best dividend stocks can work for you. |
